Clinical Research Directory
Browse clinical research sites, groups, and studies.
Dose-finding for Dobutamine During Transitional Circulation in Very Preterm Infants
Sponsor: Instituto de Investigación Hospital Universitario La Paz
Summary
Single centre, dose finding trial to establish the minimum effective dose of dobutamine required to treat hemodynamic insufficiency, defined as low superior vena cava (SVC) flow, in infants below 33 weeks' gestation during transitional circulation (first 72 hours from birth).
Official title: Dose-finding for Dobutamine During Transitional Circulation in the Very Preterm Infant
Key Details
Gender
All
Age Range
Any - 72 Hours
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2024-06-24
Completion Date
2029-06
Last Updated
2025-03-17
Healthy Volunteers
No
Interventions
Intravenous dobutamine 5 mcg/kg/min
Intravenous dobutamine will be administered at a dose of 5 mcg/kg/min.
Intravenous dobutamine 7.5 mcg/kg/min
Intravenous dobutamine will be administered at a dose of 7.5 mcg/kg/min.
Intravenous dobutamine 10 mcg/kg/min
Intravenous dobutamine will be administered at a dose of 10 mcg/kg/min.
Intravenous dobutamine 12.5 mcg/kg/min
Intravenous dobutamine will be administered at a dose of 12.5 mcg/kg/min.
Intravenous dobutamine 15 mcg/kg/min
Intravenous dobutamine will be administered at a dose of 15 mcg/kg/min.
Locations (3)
Hospital Universitario Quironsalud
Madrid, Spain
Hospital Universitario 12 de Octubre
Madrid, Spain
Hospital Universitario La Paz
Madrid, Spain